Ronald Peck - 23 Feb 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Medical Officer
Signature
/s/ Matthew Batters as attorney-in-fact for Ronald Peck
Issuer symbol
ARVN
Transactions as of
23 Feb 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 20:00:27 UTC
Previous filing
04 Jan 2022
Next filing
16 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Stock Option (right to buy) Award $0 +67,000 $0.000000 67,000 23 Feb 2022 Common Stock 67,000 $64.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.